Addex Therapeutics Stock Performance

ADXN Stock  USD 20.05  0.91  4.34%   
Addex Therapeutics holds a performance score of 18 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.75, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Addex Therapeutics will likely underperform. Use Addex Therapeutics standard deviation, expected short fall, period momentum indicator, as well as the relationship between the maximum drawdown and rate of daily change , to analyze future returns on Addex Therapeutics.

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Addex Therapeutics are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, Addex Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
(7.56)
Five Day Return
(21.56)
Year To Date Return
218.25
Ten Year Return
38.28
All Time Return
38.28
Last Split Factor
1:20
Last Split Date
2023-10-23
1
ADRs Close Higher Addex Therapeutics Climbs 21 percent - Morningstar
01/25/2024
2
Addex Therapeutics Ltd Short Interest Update
01/31/2024
3
Addex Therapeutics Ltd Sees Significant Increase in Short Interest - Defense World
03/14/2024
4
Addex stock climbs on launch of new company, Neurosterix
04/03/2024
5
Addex Therapeutics Ltd Short Interest Update - Defense World
04/12/2024
6
ADXN Stock Earnings Addex Therapeutics Reported Results for Q4 2023
04/18/2024
Begin Period Cash FlowM
  

Addex Therapeutics Relative Risk vs. Return Landscape

If you would invest  707.00  in Addex Therapeutics on January 21, 2024 and sell it today you would earn a total of  1,298  from holding Addex Therapeutics or generate 183.59% return on investment over 90 days. Addex Therapeutics is currently generating 1.9473% in daily expected returns and assumes 8.1441% risk (volatility on return distribution) over the 90 days horizon. In different words, 72% of stocks are less volatile than Addex, and 62% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Addex Therapeutics is expected to generate 13.28 times more return on investment than the market. However, the company is 13.28 times more volatile than its market benchmark. It trades about 0.24 of its potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.1 per unit of risk.

Addex Therapeutics Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Addex Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Addex Therapeutics, and traders can use it to determine the average amount a Addex Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.2391

Best PortfolioBest Equity
Good Returns
Average ReturnsADXN
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 8.14
  actual daily
71
71% of assets are less volatile

Expected Return

 1.95
  actual daily
38
62% of assets have higher returns

Risk-Adjusted Return

 0.24
  actual daily
18
82% of assets perform better
Based on monthly moving average Addex Therapeutics is performing at about 18% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Addex Therapeutics by adding it to a well-diversified portfolio.

Addex Therapeutics Fundamentals Growth

Addex Stock prices reflect investors' perceptions of the future prospects and financial health of Addex Therapeutics, and Addex Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Addex Stock performance.

About Addex Therapeutics Performance

To evaluate Addex Therapeutics Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Addex Therapeutics generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Addex Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Addex Therapeutics market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Addex's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand-25 K-23.8 K
Return On Tangible Assets(2.27)(2.16)
Return On Capital Employed(5.88)(5.59)
Return On Assets(2.27)(2.16)
Return On Equity(9.22)(8.75)

Things to note about Addex Therapeutics performance evaluation

Checking the ongoing alerts about Addex Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Addex Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Addex Therapeutics is way too risky over 90 days horizon
Addex Therapeutics appears to be risky and price may revert if volatility continues
Addex Therapeutics has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 1.61 M. Net Loss for the year was (10.56 M) with profit before overhead, payroll, taxes, and interest of 1.44 M.
Addex Therapeutics currently holds about 8.81 M in cash with (7.99 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.4.
Latest headline from investorplace.com: ADXN Stock Earnings Addex Therapeutics Reported Results for Q4 2023
Evaluating Addex Therapeutics' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Addex Therapeutics' stock performance include:
  • Analyzing Addex Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Addex Therapeutics' stock is overvalued or undervalued compared to its peers.
  • Examining Addex Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Addex Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Addex Therapeutics' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Addex Therapeutics' stock. These opinions can provide insight into Addex Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Addex Therapeutics' stock performance is not an exact science, and many factors can impact Addex Therapeutics' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Addex Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Addex Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Addex Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Addex Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for Addex Stock analysis

When running Addex Therapeutics' price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Global Correlations
Find global opportunities by holding instruments from different markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Is Addex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(18.45)
Revenue Per Share
2.64
Quarterly Revenue Growth
(0.69)
Return On Assets
(0.99)
Return On Equity
(3.48)
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.